Susanne Schaffert
CIK 1938363 · last filed 2025-06-12
Susanne Schaffert is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for INCY, was dated Jun 12, 2025. Current disclosed insider exposure totals $801.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$801.9K
2
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 7,389 | $108.53 | $801.9K | $0 | 4 | 2025-06-12 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | — | $0.08 | — | $0 | 1 | 2022-08-01 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-12 | INCY | Mixed | +1,669 | -$59.5K | EDGAR |
| 2024-06-14 | INCY | Mixed | +2,078 | -$45.1K | EDGAR |
| 2023-06-16 | INCY | Mixed | +2,017 | -$30.0K | EDGAR |
| 2022-10-05 | INCY | Grant (A) | +1,625 | $0 | EDGAR |
| 2022-08-01 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |